Stock Rating Downgrade
Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Harrow Health Inc (NASDAQ: HROW) weakened of late. HROW’s current Value Trend Rating is C and the prior Rating was B. Details supporting this lower rating are included in our next report.
Recent Price Action
On 8/9/24, Harrow Health Inc (NASDAQ: HROW) stock enjoyed a very large increase of 6.0%, closing at $35.94. Moreover, exceptionally high trading volume at 310% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 46.4% during the last week.
Current PriceTarget Research Rating
HROW is expected to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Harrow Health has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Harrow Health has a poor Appreciation Score of 16 but a very high Power Rating of 97, producing the High Neutral Value Trend Rating.
Be the first to comment